Report Overview
Report Overview
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pharmacovigilance market size was estimated at USD 5230.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance market.
Global Pharmacovigilance Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences
Market Segmentation (by Type)
Chemotherapy
Contract Outsourcing
Market Segmentation (by Application)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacovigilance Market
Overview of the regional outlook of the Pharmacovigilance Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Pharmacovigilance
- 1.2 Key Market Segments
- 1.2.1 Pharmacovigilance Segment by Type
- 1.2.2 Pharmacovigilance Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Pharmacovigilance Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Pharmacovigilance Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Pharmacovigilance Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Pharmacovigilance Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Pharmacovigilance Product Life Cycle
- 3.3 Global Pharmacovigilance Sales by Manufacturers (2020-2025)
- 3.4 Global Pharmacovigilance Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Pharmacovigilance Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Pharmacovigilance Market Competitive Situation and Trends
- 3.8.1 Pharmacovigilance Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Pharmacovigilance Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Pharmacovigilance Industry Chain Analysis
- 4.1 Pharmacovigilance Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Pharmacovigilance Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Pharmacovigilance Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance Market
- 5.7 ESG Ratings of Leading Companies
- 6 Pharmacovigilance Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Pharmacovigilance Sales Market Share by Type (2020-2025)
- 6.3 Global Pharmacovigilance Market Size by Type (2020-2025)
- 6.4 Global Pharmacovigilance Price by Type (2020-2025)
- 7 Pharmacovigilance Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Pharmacovigilance Market Sales by Application (2020-2025)
- 7.3 Global Pharmacovigilance Market Size (M USD) by Application (2020-2025)
- 7.4 Global Pharmacovigilance Sales Growth Rate by Application (2020-2025)
- 8 Pharmacovigilance Market Sales by Region
- 8.1 Global Pharmacovigilance Sales by Region
- 8.1.1 Global Pharmacovigilance Sales by Region
- 8.1.2 Global Pharmacovigilance Sales Market Share by Region
- 8.2 Global Pharmacovigilance Market Size by Region
- 8.2.1 Global Pharmacovigilance Market Size by Region
- 8.2.2 Global Pharmacovigilance Market Size by Region
- 8.3 North America
- 8.3.1 North America Pharmacovigilance Sales by Country
- 8.3.2 North America Pharmacovigilance Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Pharmacovigilance Sales by Country
- 8.4.2 Europe Pharmacovigilance Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Pharmacovigilance Sales by Region
- 8.5.2 Asia Pacific Pharmacovigilance Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Pharmacovigilance Sales by Country
- 8.6.2 South America Pharmacovigilance Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Pharmacovigilance Sales by Region
- 8.7.2 Middle East and Africa Pharmacovigilance Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Pharmacovigilance Sales by Region
- 9 Pharmacovigilance Market Production by Region
- 9.1 Global Production of Pharmacovigilance by Region(2020-2025)
- 9.2 Global Pharmacovigilance Revenue Market Share by Region (2020-2025)
- 9.3 Global Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Pharmacovigilance Production
- 9.4.1 North America Pharmacovigilance Production Growth Rate (2020-2025)
- 9.4.2 North America Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Pharmacovigilance Production
- 9.5.1 Europe Pharmacovigilance Production Growth Rate (2020-2025)
- 9.5.2 Europe Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Pharmacovigilance Production (2020-2025)
- 9.6.1 Japan Pharmacovigilance Production Growth Rate (2020-2025)
- 9.6.2 Japan Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Pharmacovigilance Production (2020-2025)
- 9.7.1 China Pharmacovigilance Production Growth Rate (2020-2025)
- 9.7.2 China Pharmacovigilance Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Eli Lilly and Company
- 10.1.1 Eli Lilly and Company Basic Information
- 10.1.2 Eli Lilly and Company Pharmacovigilance Product Overview
- 10.1.3 Eli Lilly and Company Pharmacovigilance Product Market Performance
- 10.1.4 Eli Lilly and Company Business Overview
- 10.1.5 Eli Lilly and Company SWOT Analysis
- 10.1.6 Eli Lilly and Company Recent Developments
- 10.2 ICON
- 10.2.1 ICON Basic Information
- 10.2.2 ICON Pharmacovigilance Product Overview
- 10.2.3 ICON Pharmacovigilance Product Market Performance
- 10.2.4 ICON Business Overview
- 10.2.5 ICON SWOT Analysis
- 10.2.6 ICON Recent Developments
- 10.3 Elsevier
- 10.3.1 Elsevier Basic Information
- 10.3.2 Elsevier Pharmacovigilance Product Overview
- 10.3.3 Elsevier Pharmacovigilance Product Market Performance
- 10.3.4 Elsevier Business Overview
- 10.3.5 Elsevier SWOT Analysis
- 10.3.6 Elsevier Recent Developments
- 10.4 Chiltern
- 10.4.1 Chiltern Basic Information
- 10.4.2 Chiltern Pharmacovigilance Product Overview
- 10.4.3 Chiltern Pharmacovigilance Product Market Performance
- 10.4.4 Chiltern Business Overview
- 10.4.5 Chiltern Recent Developments
- 10.5 Atlantic Research Group
- 10.5.1 Atlantic Research Group Basic Information
- 10.5.2 Atlantic Research Group Pharmacovigilance Product Overview
- 10.5.3 Atlantic Research Group Pharmacovigilance Product Market Performance
- 10.5.4 Atlantic Research Group Business Overview
- 10.5.5 Atlantic Research Group Recent Developments
- 10.6 Mapi Group
- 10.6.1 Mapi Group Basic Information
- 10.6.2 Mapi Group Pharmacovigilance Product Overview
- 10.6.3 Mapi Group Pharmacovigilance Product Market Performance
- 10.6.4 Mapi Group Business Overview
- 10.6.5 Mapi Group Recent Developments
- 10.7 Accenture
- 10.7.1 Accenture Basic Information
- 10.7.2 Accenture Pharmacovigilance Product Overview
- 10.7.3 Accenture Pharmacovigilance Product Market Performance
- 10.7.4 Accenture Business Overview
- 10.7.5 Accenture Recent Developments
- 10.8 Clinquest Group
- 10.8.1 Clinquest Group Basic Information
- 10.8.2 Clinquest Group Pharmacovigilance Product Overview
- 10.8.3 Clinquest Group Pharmacovigilance Product Market Performance
- 10.8.4 Clinquest Group Business Overview
- 10.8.5 Clinquest Group Recent Developments
- 10.9 GSK
- 10.9.1 GSK Basic Information
- 10.9.2 GSK Pharmacovigilance Product Overview
- 10.9.3 GSK Pharmacovigilance Product Market Performance
- 10.9.4 GSK Business Overview
- 10.9.5 GSK Recent Developments
- 10.10 PRA Health Sciences
- 10.10.1 PRA Health Sciences Basic Information
- 10.10.2 PRA Health Sciences Pharmacovigilance Product Overview
- 10.10.3 PRA Health Sciences Pharmacovigilance Product Market Performance
- 10.10.4 PRA Health Sciences Business Overview
- 10.10.5 PRA Health Sciences Recent Developments
- 10.1 Eli Lilly and Company
- 11 Pharmacovigilance Market Forecast by Region
- 11.1 Global Pharmacovigilance Market Size Forecast
- 11.2 Global Pharmacovigilance Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Pharmacovigilance Market Size Forecast by Country
- 11.2.3 Asia Pacific Pharmacovigilance Market Size Forecast by Region
- 11.2.4 South America Pharmacovigilance Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Pharmacovigilance Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Pharmacovigilance by Type (2026-2035)
- 12.1.2 Global Pharmacovigilance Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Pharmacovigilance by Type (2026-2035)
- 12.2 Global Pharmacovigilance Market Forecast by Application (2026-2035)
- 12.2.1 Global Pharmacovigilance Sales (K Units) Forecast by Application
- 12.2.2 Global Pharmacovigilance Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Pharmacovigilance Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings